on ABSCIENCES (EPA:AB)
AB Science Completes EUR 2.55 Million Private Placement
AB Science S.A. has completed a private placement raising EUR 2.55 million. This move involved issuing 2,276,787 new shares with share warrants attached. The funds are earmarked for ongoing operations, notably the AB8939 clinical development program.
The new shares and associated warrants represent a 3.23% dilution of the company's share capital post-transaction. The issue price of the shares, set at EUR 1.12 each, reflects a 17.87% discount relative to the average recent trading price. AB Science's capital now comprises 63,706,916 ordinary shares.
The transaction strengthens AB Science's financial position, ensuring funding through 2025. The new shares are expected to begin trading on Euronext Paris on August 7, 2025.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABSCIENCES news